Dougherty Darin D
Division of Neurotherapeutics, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, CNY2612, 149 13th Street, Boston, MA 02129, USA.
Psychiatr Clin North Am. 2018 Sep;41(3):385-394. doi: 10.1016/j.psc.2018.04.004. Epub 2018 Jul 17.
Deep brain stimulation has been used for decades in neurology to treat movement disorders. More recent work has focused on developing applications for deep brain stimulation in psychiatric illness. Initial studies have demonstrated positive results for treatment-refractory obsessive-compulsive disorder. Initial open-label studies of deep brain stimulation at targets for treatment-resistant depression have been encouraging. However, the only 2 published controlled trials that were conducted for potential FDA approval for treatment-resistant depression were both negative. Future directions include potential use of alternate clinical trial designs, using tractography for more refined deep brain stimulation electrode targeting, and closed-loop deep brain stimulation approaches.
几十年来,深部脑刺激已在神经病学中用于治疗运动障碍。最近的工作重点是开发深部脑刺激在精神疾病中的应用。初步研究已证明对难治性强迫症的治疗有积极效果。针对难治性抑郁症靶点进行深部脑刺激的初步开放标签研究令人鼓舞。然而,为获得美国食品药品监督管理局(FDA)对难治性抑郁症治疗的潜在批准而进行的仅有的两项已发表的对照试验均为阴性。未来的方向包括可能使用替代临床试验设计、利用神经纤维束成像进行更精确的深部脑刺激电极靶向,以及闭环深部脑刺激方法。